Natco Pharma Ltd - Stock Price

As on31 Mar 2020 03:59 PM Closed
  • NSE : NATCOPHARM
  • BSE : 524816
  • ISIN CODE : INE987B01026
  • Industry : Pharmaceuticals & Drugs
  • House : Natco
Natco Pharma Ltd is not traded on BSE/NSE
505.55
+2.17 %+10.75
Previous Close 494.80
Day's Open 527.00
Bid Price (Qty) 505.55 (620)
Offer Price (Qty) 0.00 (0)
Day’s High - Low 527.00 - 490.15
52 Week Range 402.55 - 738.1
Volume Traded (in 000's) 101.02
Value traded (in Cr.) 5.11
PE Ratio (x) 18.47
M Cap (in Cr.)9176.23

Natco Pharma Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 9176.23
Earning Per Share (EPS TTM) (Rs.) 27.29
Price To Earnings (P/E) Ratio 18.47
Book Value Per Share (Rs.) 212.21
Price/Book (MRQ) 2.38
Price/Earning (TTM) 15.65
ROCE (%) 23.91
PAT Margin 33.59
Dividend Yield 1.24
Face Value 2

Financial Summary

Parameter MAR 19 (`Mn.) MAR 18 (`Mn.) YoY %Change
Balance Sheet :
Share Capital365.00369.00-1.08
Total Non-Current Liabilities834.00471.0077.07
Total Current Liabilities7287.005920.0023.09
Total Liabilities43031.0037151.0015.83
Total Non-Current Assets19559.0015844.0023.45
Currents Investments1487.00684.00117.40
Cash and Bank2795.001837.0052.15
Total Current Assets23472.0021307.0010.16
Total Assets43031.0037151.0015.83
Profit & Loss :
Gross Sales20945.0022020.00-4.88
Net Sales20945.0021848.00-4.13
Total Expenditure12997.0012564.003.45
Operating Profit9250.009688.00-4.52
Profit After Tax6424.006952.00-7.59
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
IDBI Healthcare Fund-Reg(G)3.79
Aditya Birla SL Resurgent India Fund-2-Reg(G)3.49
Aditya Birla SL Resurgent India Fund-1-Reg(G)3.33
UTI Healthcare Fund-Reg(D)3.22
Aditya Birla SL Equity Advantage Fund(D)2.35
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)2.26
More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Peer Comparison

More Comparison »

Share Holdings

Description Percent of Share (%)
Promoters48.98
Non-Institution19.4
Mutual Funds/Uti7.9
Fi/Banks/Insurance1.08
Government0
FII0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: V C Nannapaneni
  • Managing Director: V C Nannapaneni
  • Secretary: M Adinarayana

Registered Office

Address : Natco House,Road No 2,Banjara Hills, Hyderabad,
Telangana-500003 Tel : 040-23547532 Fax : 040-23548243 Email : investors@natcopharma.co.in / dasaradhi@natcopharma.co.in Website : www.natcopharma.co.in

Registars Details

Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 503.25. Its current market capitalisation stands at Rs 9176.23 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20945 Cr and Total Income of Rs.22247 Cr. The company's management includes Sridhar Sankararaman, D Linga Rao, MUR Naidu, PSRK Prasad, Leela Digumarti, DG Prasad, Rajeev Nannapaneni, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Latest News

close